Clinical Trial: Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514728) titled 'Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen' on March 19.

Brief Summary: This is a proof-of-concept clinical trial focused on exploring whether hyperbaric oxygen therapy (HBOT) can inhibit the progression of lung metastasis in breast cancer patients. Patients enrolled in this arm will receive standard breast cancer treatment combined with HBOT.

Study Start Date: Nov. 24, 2025

Study Type: INTERVENTIONAL

Condition: Breast Cancer Lung Metastasis Hyperbaric Oxygen Therapy

Intervention: DEVICE: Hyperbaric Oxygen Therapy

The HBOT regimen will consist of 6 s...